Development of a Kidney Calcification Inhibitor Employing Image-Based Profiling: A Proof-of-Concept Study

Area of Science:

• Nephrology
• Pharmacology
• Biochemistry

Background:

• Kidney calcification, driven by renal calcium phosphate crystallization, elevates chronic kidney disease risk.
• Renal calcium phosphate crystallization remains an underexplored therapeutic target for kidney calcification.
• Pre-clinical drug development for kidney calcification is hindered by limited understanding of multifactorial disease progression.

Purpose of the Study:

• To establish an in vitro calcification profiling platform for accelerated pre-clinical drug discovery.
• To identify novel inhibitors of renal calcium phosphate crystallization.
• To evaluate the efficacy of identified inhibitors in preventing kidney damage.

Main Methods:

• Development of an image-based in vitro calcification profiling assay.
• Screening of an inositol hexakisphosphate analogue library for inhibitory activity.
• In vitro and in vivo testing of lead compounds for efficacy against calcium phosphate-induced kidney damage.

Main Results:

• A novel renal calcium phosphate inhibitor was identified from the inositol hexakisphosphate analogue library.
• The lead compound demonstrated significant in vitro efficacy in preventing calcium phosphate-induced kidney damage.
• The lead compound also showed in vivo efficacy in preventing kidney damage.

Conclusions:

• A potent renal calcium phosphate inhibitor was discovered, offering a potential therapeutic strategy for kidney calcification.
• The developed in vitro calcification platform proves valuable for accelerating pre-clinical drug discovery in nephrology.
• This research underscores the translational value of the in vitro platform and the identified inhibitor for reducing kidney damage.